




Searching News Database: CUSTOM II
HSMN NewsFeed - 13 May 2008
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
HSMN NewsFeed - 22 May 2007
XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
HSMN NewsFeed - 16 May 2006
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
HSMN NewsFeed - 15 May 2006
SurModics Provides Hydrophilic Coating on Xtent's Drug-Eluting Stent Delivery System
SurModics Provides Hydrophilic Coating on Xtent's Drug-Eluting Stent Delivery System
HSMN NewsFeed - 17 Feb 2006
Xtent's Drug-Eluting Stent Technology Witnessed Live During Prominent Interventional Meeting in Rome, Italy
Xtent's Drug-Eluting Stent Technology Witnessed Live During Prominent Interventional Meeting in Rome, Italy
Additional items found! 1

Members Archive contains
1 additional stories matching:
CUSTOM II
(Password required)
CUSTOM II
(Password required)